top of page
MyotonicPipeline.com
Arthex Biotech
Approach: antisense oligonucleotides targeting microRNA
Updates:
July 23, 2020: Article discussing raise of 4.25 million euros in funding
July 2021 study Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
June 10, 2022 presentation for Myotonic Dystrophy Foundation
bottom of page